NO20071912L - Donepezilsalter egnet for fremstilling av farmasoytiske sammensetninger. - Google Patents
Donepezilsalter egnet for fremstilling av farmasoytiske sammensetninger.Info
- Publication number
- NO20071912L NO20071912L NO20071912A NO20071912A NO20071912L NO 20071912 L NO20071912 L NO 20071912L NO 20071912 A NO20071912 A NO 20071912A NO 20071912 A NO20071912 A NO 20071912A NO 20071912 L NO20071912 L NO 20071912L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- pharmaceutical compositions
- salts suitable
- donepezil
- donepezil salts
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title abstract 3
- ADEBPBSSDYVVLD-UHFFFAOYSA-N donepezil Chemical class O=C1C=2C=C(OC)C(OC)=CC=2CC1CC(CC1)CCN1CC1=CC=CC=C1 ADEBPBSSDYVVLD-UHFFFAOYSA-N 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 235000005985 organic acids Nutrition 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0401850A HUP0401850A3 (en) | 2004-09-15 | 2004-09-15 | Donepezil salts for producing pharmaceutical composition |
| PCT/HU2005/000102 WO2006030249A1 (en) | 2004-09-15 | 2005-09-12 | Donepezil salts suitable for the preparation of pharmaceutical compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20071912L true NO20071912L (no) | 2007-06-07 |
Family
ID=89985497
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20071912A NO20071912L (no) | 2004-09-15 | 2007-04-16 | Donepezilsalter egnet for fremstilling av farmasoytiske sammensetninger. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20080194628A1 (zh) |
| EP (1) | EP1817286A1 (zh) |
| CN (1) | CN101039910A (zh) |
| BG (1) | BG109855A (zh) |
| CZ (1) | CZ2007248A3 (zh) |
| EA (1) | EA200700637A1 (zh) |
| HU (1) | HUP0401850A3 (zh) |
| IL (1) | IL181827A0 (zh) |
| NO (1) | NO20071912L (zh) |
| PL (1) | PL382842A1 (zh) |
| RU (1) | RU2382032C2 (zh) |
| SK (1) | SK50342007A3 (zh) |
| UA (1) | UA88481C2 (zh) |
| WO (1) | WO2006030249A1 (zh) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102004046497A1 (de) * | 2004-09-23 | 2006-04-06 | Helm Ag | Donepezil-Salze |
| IL171137A (en) * | 2004-09-29 | 2012-01-31 | Chemagis Ltd | Use of purified malt donfazil for the preparation of pure pharmaceutical amorphous donfazil hydrochloride |
| WO2007010910A1 (en) * | 2005-07-15 | 2007-01-25 | Eisai R & D Management Co., Ltd. | 1-benzyl-4-[(5, 6-dimethoxy-1-indanon)-2-yl]-methyl piperidine p-toluenesulfonate or crystal thereof |
| US20100113793A1 (en) * | 2006-03-20 | 2010-05-06 | Ind-Swift Laboratories Limited | Process for the Preparation of Highly Pure Donepezil |
| GB0609835D0 (en) * | 2006-05-18 | 2006-06-28 | Pliva Istrazivanje I Razvoj D | Impurities of a pharmaceutical product |
| CN101167697B (zh) * | 2006-10-26 | 2011-03-30 | 中国科学院上海药物研究所 | 多奈哌齐类化合物长效缓控释组合物及其制备方法 |
| ES2415166T3 (es) * | 2007-09-28 | 2013-07-24 | Tianjin Hemay Bio-Tech Co., Ltd. | Polímorfos de sales de Donepezilo, métodos de preparación y usos de los mismos |
| WO2010033045A1 (en) * | 2008-09-16 | 2010-03-25 | Igor Anatolievich Pomytkin | Compositions and methods for prevention or treatment of beta amyloid deposition |
| US20140243278A1 (en) * | 2011-07-05 | 2014-08-28 | Sunil Sadanand Nadkarni | Acid Addition Salt of Donepezil and Pharmaceutical Composition Thereof |
| EP2586436A1 (en) | 2011-10-31 | 2013-05-01 | Commissariat à l'Énergie Atomique et aux Énergies Alternatives | Use of anti-connexin agents for enhancing the therapeutic effect of acetylcholinesterase inhibitor |
| WO2013078608A1 (en) | 2011-11-29 | 2013-06-06 | Ziqiang Gu | Donepezil pamoate and methods of making and using the same |
| KR101811797B1 (ko) * | 2013-04-03 | 2017-12-22 | 동국제약 주식회사 | 도네페질을 포함하는 비경구투여용 약제학적 조성물 |
| US11197850B2 (en) | 2017-02-23 | 2021-12-14 | Shanghai Synergy Pharmaceutical Sciences Co., Ltd. | Powder injection of the donepezil semi palmoxiric acid salt, composition containing same and preparation method therefor |
| US20220023276A1 (en) * | 2018-11-26 | 2022-01-27 | Industry-Academic Cooperation Foundation, Yonsei University | Donepezil eutectic mixture and use thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI95572C (fi) * | 1987-06-22 | 1996-02-26 | Eisai Co Ltd | Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi |
| DK1086706T3 (da) * | 1999-03-31 | 2004-03-08 | Eisai Co Ltd | Stabiliserede sammensætninger indeholdende nootropiske lægemidler |
| US7091218B1 (en) * | 1999-09-01 | 2006-08-15 | Eisai Co., Ltd. | 4-substituted piperidine compound |
| EP1285656A4 (en) * | 2000-04-13 | 2006-07-12 | Eisai Co Ltd | ACETYLCHOLINESTERASE HEMMER CONTAINING 1-BENZYLPYRIDINIUM SALT |
| US7439365B2 (en) * | 2003-11-17 | 2008-10-21 | Usv, Ltd. | Pharmaceutical salt of (1-benzyl-4-[(5,6-dimethoxy-1-indanone)-2-yl] methyl piperidine (Donepezil) |
-
2004
- 2004-09-15 HU HU0401850A patent/HUP0401850A3/hu unknown
-
2005
- 2005-09-12 WO PCT/HU2005/000102 patent/WO2006030249A1/en active Application Filing
- 2005-09-12 SK SK5034-2007A patent/SK50342007A3/sk not_active Application Discontinuation
- 2005-09-12 EA EA200700637A patent/EA200700637A1/ru unknown
- 2005-09-12 CZ CZ20070248A patent/CZ2007248A3/cs unknown
- 2005-09-12 CN CNA2005800348076A patent/CN101039910A/zh active Pending
- 2005-09-12 PL PL382842A patent/PL382842A1/pl not_active Application Discontinuation
- 2005-09-12 RU RU2007114082/04A patent/RU2382032C2/ru not_active IP Right Cessation
- 2005-09-12 EP EP05787910A patent/EP1817286A1/en not_active Withdrawn
- 2005-09-12 UA UAA200704106A patent/UA88481C2/ru unknown
- 2005-12-09 US US11/662,867 patent/US20080194628A1/en not_active Abandoned
-
2007
- 2007-03-08 IL IL181827A patent/IL181827A0/en unknown
- 2007-04-13 BG BG109855A patent/BG109855A/bg unknown
- 2007-04-16 NO NO20071912A patent/NO20071912L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN101039910A (zh) | 2007-09-19 |
| EP1817286A1 (en) | 2007-08-15 |
| EA200700637A1 (ru) | 2007-08-31 |
| CZ2007248A3 (cs) | 2007-06-20 |
| HUP0401850A2 (en) | 2006-11-28 |
| SK50342007A3 (sk) | 2007-07-06 |
| IL181827A0 (en) | 2007-07-04 |
| RU2007114082A (ru) | 2008-10-27 |
| US20080194628A1 (en) | 2008-08-14 |
| UA88481C2 (ru) | 2009-10-26 |
| PL382842A1 (pl) | 2008-01-21 |
| HUP0401850A3 (en) | 2008-03-28 |
| WO2006030249A1 (en) | 2006-03-23 |
| BG109855A (bg) | 2008-04-30 |
| RU2382032C2 (ru) | 2010-02-20 |
| HU0401850D0 (en) | 2004-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20071912L (no) | Donepezilsalter egnet for fremstilling av farmasoytiske sammensetninger. | |
| NO20055496L (no) | Pyrazolokinazolinderivater, metoder for deres fremstilling og deres anvendelse som kinaseinhibitorer | |
| DE60323090D1 (de) | 1h-imidazoä4,5-cüchinolinderivate zur behandlung von protein kinase-abhängigen krankheiten | |
| WO2005097135A3 (en) | Use of 9h-purine-2,6-diamine derivatives in the treatment of proliferative diseases and novel 9h-purine-2,6-diamine derivatives | |
| NO20082530L (no) | Imidazopyraziner som proteinkinaseinhibitorer | |
| GEP20084367B (en) | Diazepinoindole derivatives as kinase inhibitors | |
| NO20090443L (no) | 2-metylmorfolin pyrido-, pyrazo- and pyrimido-pyrimidin derivater | |
| BRPI0515931A (pt) | compostos, processo para a sua preparação, composições farmacêuticas que os compreendem, método para o tratamento e/ou profilaxia de enfermidades e utilização desses compostos | |
| NZ597059A (en) | Inhibitors of influenza viruses replication | |
| NO20054763L (no) | Salter av clopidogrel og fremgangsmate for fremstilling derav | |
| PL2324008T3 (pl) | 3,4-diarylopirazole jako inhibitory kinazy białkowej | |
| MXPA06000302A (es) | Derivados de pirazolil-indol activos como inhibidores de cinasa, procedimientos para su preparacion y composiciones farmaceuticas que los comprenden. | |
| TN2009000070A1 (en) | Benzoxazoles and oxazolopyridines being useful as janus kinases inhibitors | |
| DE502005008971D1 (de) | Substituierte 1,4,8-triazaspiroä4.5 decan-2-on-verbindungen zur behandlung von fettsucht | |
| TW200612922A (en) | Inhibitors of hsp90 | |
| NO20076425L (no) | Fremgangsmater for behandling av drug-resistent cancer | |
| NO20053809L (no) | Diarylmetylindenpiperidinderivater,fremgangsmate for fremstilling derav, og anvendelse derav | |
| ATE433450T1 (de) | Substituierte 1,4,8-triazaspiro 4.5 decan-2-on- verbindungen | |
| BRPI0413438A (pt) | derivados de pirimidilpirrol ativos como inibidores de cinase | |
| DK1869038T3 (da) | Substituerede 5,6,7,8-tetrahydro-imidazol[1,2-a]pyridin-2-ylamin-forbindelser og deres anvendelse til fremstilling af lægemidler | |
| DE502004008819D1 (de) | Medikament zur wachstumsinhibierung von tumoren | |
| NO20073176L (no) | Nye medikamenter for behandling av luftveissykdommer | |
| SE0950390L (sv) | System och process för tillverkning av en lösning med suspenderade fasta ämnen och användningar därför | |
| CY1112638T1 (el) | Χρηση των παραγωγων ινδολιου ως ενεργοποιητες νurr-1 για την θεραπεια νοσου ραrκινsον | |
| NO20056042L (no) | Forbindelser som er anvendelige til behandling av Alzheimers sykdom samt formuleringer inneholdende disse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |